- Home
- BEEM vs SNTI Comparison
BEEM vs SNTI Comparison
Compare BEEM & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- SNTI
- Stock Information
- Founded
- BEEM 2006
- SNTI 2016
- Country
- BEEM United States
- SNTI United States
- Employees
- BEEM N/A
- SNTI N/A
- Industry
- BEEM Semiconductors
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- SNTI Health Care
- Exchange
- BEEM Nasdaq
- SNTI Nasdaq
- Market Cap
- BEEM 35.5M
- SNTI 39.6M
- IPO Year
- BEEM N/A
- SNTI N/A
- Fundamental
- Price
- BEEM $2.35
- SNTI $1.35
- Analyst Decision
- BEEM Strong Buy
- SNTI Strong Buy
- Analyst Count
- BEEM 4
- SNTI 2
- Target Price
- BEEM $5.33
- SNTI $8.50
- AVG Volume (30 Days)
- BEEM 190.8K
- SNTI 124.8K
- Earning Date
- BEEM 11-13-2025
- SNTI 11-13-2025
- Dividend Yield
- BEEM N/A
- SNTI N/A
- EPS Growth
- BEEM N/A
- SNTI N/A
- EPS
- BEEM N/A
- SNTI N/A
- Revenue
- BEEM $33,362,000.00
- SNTI N/A
- Revenue This Year
- BEEM N/A
- SNTI N/A
- Revenue Next Year
- BEEM $45.38
- SNTI $150.00
- P/E Ratio
- BEEM N/A
- SNTI N/A
- Revenue Growth
- BEEM N/A
- SNTI N/A
- 52 Week Low
- BEEM $1.33
- SNTI $1.26
- 52 Week High
- BEEM $5.57
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- BEEM 44.39
- SNTI 33.68
- Support Level
- BEEM $2.41
- SNTI $1.38
- Resistance Level
- BEEM $2.63
- SNTI $1.39
- Average True Range (ATR)
- BEEM 0.17
- SNTI 0.08
- MACD
- BEEM -0.05
- SNTI 0.00
- Stochastic Oscillator
- BEEM 12.20
- SNTI 22.50
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.